LifeVantage (NASDAQ:LFVN) Share Price Passes Below 200-Day Moving Average of $6.49

LifeVantage Co. (NASDAQ:LFVN) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $6.49 and traded as low as $6.27. LifeVantage shares last traded at $6.27, with a volume of 47,333 shares trading hands.

LifeVantage Price Performance

The business’s 50 day moving average is $6.46 and its two-hundred day moving average is $6.48. The firm has a market capitalization of $79.92 million, a PE ratio of 27.00 and a beta of 0.80.

LifeVantage (NASDAQ:LFVN) last issued its earnings results on Tuesday, January 30th. The company reported $0.10 earnings per share (EPS) for the quarter. The firm had revenue of $51.62 million for the quarter. LifeVantage had a net margin of 1.40% and a return on equity of 19.96%.

LifeVantage Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, March 1st were given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 2.25%. The ex-dividend date was Thursday, February 29th. LifeVantage’s dividend payout ratio is currently 60.87%.

Hedge Funds Weigh In On LifeVantage

Several large investors have recently modified their holdings of LFVN. American Century Companies Inc. grew its stake in shares of LifeVantage by 30.3% during the 1st quarter. American Century Companies Inc. now owns 46,016 shares of the company’s stock valued at $219,000 after purchasing an additional 10,706 shares during the period. BlackRock Inc. grew its stake in shares of LifeVantage by 10.5% during the 1st quarter. BlackRock Inc. now owns 249,547 shares of the company’s stock valued at $1,188,000 after acquiring an additional 23,788 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of LifeVantage by 4.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 271,614 shares of the company’s stock valued at $1,293,000 after acquiring an additional 11,964 shares during the period. State Street Corp grew its stake in shares of LifeVantage by 7.6% during the 1st quarter. State Street Corp now owns 46,191 shares of the company’s stock valued at $220,000 after acquiring an additional 3,281 shares during the period. Finally, EP Wealth Advisors LLC bought a new position in shares of LifeVantage during the 1st quarter valued at approximately $234,000. Hedge funds and other institutional investors own 35.32% of the company’s stock.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.